• PerkinElmer Sells LIMS Product to New LIMS Company

    Clinical Informatics News Brief | PerkinElmer Health Sciences has sold its LABWORKS LIMS product line to Labworks, LLC, a new company comprising many previous PerkinElmer/LABWORKS employees. The LABWORKS LIMS product line has a 25-year history of LIMS excellence and a 300+ customer base. No financial details were released.

    May 11, 2016

  • STAT-Harvard poll Public wary of faster FDA approvals of drugs

    STAT |  A majority of Americans opposes regulatory changes to speed up the approval of new drugs and medical devices, a new STAT-Harvard poll finds.

    May 11, 2016

  • The pressure to publish pushes down quality

    Nature News & Comment |  Scientists must publish less, says Daniel Sarewitz, or good research will be swamped by the ever-increasing volume of poor work.

    May 11, 2016

  • Defining & Building Protocol Competitiveness

    Clinical Informatics News | Everybody is fighting for the same patient pool. To develop an advantage, AstraZeneca and Anolinx are collaborating on a competitive strategy by creating a trial design library, pseudo populations, increasing clinical efficiency, and generating a new clinical buzz word with an old idea.

    May 9, 2016

  • Best Practices: Risk Based Monitoring For A Small Staff

    Clinical Informatics News | Best Practices Finalists | When PaxVax, a small vaccine biotech, wanted to run a Phase IV trial with only its existing staff, it turned to MANA Consulting to build a workflow for risk-based monitoring that would fit within its existing budget.

    May 6, 2016

  • Envera Health raises $14M for patient engagement platform

    MobiHealthNews |  Richmond, Virginia-based patient engagement company Envera Health has raised $14 million in a round led by Harbert Venture Partners and Noro-Moseley Partners with participation from New Richmond Ventures.

    May 4, 2016

  • IMS Health, Quintiles Announce Merger

    Clinical Informatics News Brief | IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. announced today that their respective boards of directors approved a definitive merger agreement, in which the companies will be combined in an all-stock merger of equals transaction. The merged company will be named Quintiles IMS Holdings, Inc.

    May 3, 2016

  • Personalized Trials: Finding the Right Trial for the Patient

    Clinical Informatics News | A team of bioinformaticians at Cincinnati Children’s Hospital has applied machine learning to predict which patients will participate in clinical trials. When physicians approached patients, 60% of them agreed to participate in trials. Using an algorithm to predict trial interest, the researchers pushed the acceptance rates to 72%.

    May 3, 2016

  • FDA Slowly Chips Away at ANDA Backlog

    RAPS |  The number of abbreviated new drug applications (ANDAs) pending review is declining according to the latest numbers from FDA. Instead, FDA is waiting to hear industry responses.

    May 2, 2016

  • CBER Unveils New Electronic Reporting System for Vaccine Adverse Events

    RAPS |  FDA's Center for Biologics Evaluation and Research has released an electronic submission system for companies to submit adverse events linked to vaccines.

    Apr 28, 2016

  • MolecularMatch Works to Commercialize Clinical-Trial-Matching Software

    Clinical Informatics News | MolecularMatch runs a free online search engine for clinical trials, with a registry that is beginning to rival clinicaltrials.gov. Now it wants to arm pathology labs with the same context-aware search engine to help interpret the results of molecular tests.

    Apr 28, 2016

  • Apple’s CareKit and the AI future of medical care

    Computerworld |  Apple's focus on personal health through connected devices ramps up a little more today with the release of the first four third party apps to integrate its newly announced open source CareKit technologies.

    Apr 28, 2016

  • Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients

    Forbes |  Last night, a panel of advisors to the Food and Drug Administration voted 7 to 3, with 3 abstentions, that the agency should not approve eteplirsen, a drug for a Duchenne muscular dystrophy, a rare, deadly, muscle-destroying disease, developed by Sarepta, a Cambridge, Mass.-based biotechnology firm. (On another vote, which [...]

    Apr 28, 2016

  • April Clinical News and Product Briefs

    Clinical Informatics News | The latest announcements and product releases from around the industry, including a major data sharing initiative for BRCA testing, and LifeMap Solutions' tailored service for smartphone-enabled research studies.

    Apr 27, 2016